IL-32 is a metabolic regulator promoting survival and proliferation of malignant plasma cells
Kristin Roseth Aass(Norwegian University of Science and Technology), Therese Standal(Norwegian University of Science and Technology)
Cited by 2
Related Papers
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
|Blood Advances|2017|73
Caspase‐8 regulates the expression of pro‐ and anti‐inflammatory cytokines in human bone marrow‐derived mesenchymal stromal cells
|Immunity Inflammation and Disease|2016|13
IL-32 is induced by activation of toll-like receptors in multiple myeloma cells
|Frontiers in Immunology|2023|7
The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
|Frontiers in Oncology|2023|5
Multiplexed Imaging Reveals Immune-Metabolic Niches in Multiple Myeloma Linked to Progression and Bone Disease
|Blood Cancer Discovery|2026|2